Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto A Novoa

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Pigment Cell & Melanoma Research|January 24, 2019
Biomarker discovery analysis: Alterations in p14, p16, p53, and BAP1 expression in nevi, cutaneous melanoma, and metastatic melanomaMichael R Sargen, Jeffrey M Cloutier, Kavita Y Sarin, et al.
Journal of Cutaneous Pathology|March 24, 2020
TERT and TERT promoter in melanocytic neoplasms: Current concepts in pathogenesis, diagnosis, and prognosisKiran Motaparthi, Jinah Kim, Aleodor A Andea, et al.
Journal of Cutaneous Pathology|July 19, 2020
Diffuse PRAME expression is highly specific for malignant melanoma in the distinction from clear cell sarcomaShyam S Raghavan, Jennifer Y Wang, Angus Toland, et al.
Journal of Cutaneous Pathology|January 14, 2017
Gain of CD26 expression on the malignant T-cells in relapsed erythrodermic leukemic mycosis fungoidesFiliberto Cedeno-Laurent, Maria Wysocka, Amrom E Obstfeld, et al.
Journal of Cutaneous Pathology|June 21, 2025
Metastatic Gastrointestinal Stromal Tumor to the Scalp: A Case Report Highlighting Diagnostic Challenges and Molecular CorrelationAndrew C Sanchez, Oyewale O Shiyanbola, Xiaohua Qian, et al.
Journal of Cutaneous Pathology|July 25, 2018
Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologistsPatrick O Emanuel, Aleodor A Andea, Claudia I Vidal, et al.
Journal of the American Academy of Dermatology|December 7, 2021
Histologic subtype of cutaneous immune-related adverse events predicts overall survival in patients receiving immune checkpoint inhibitorsKelsey E Hirotsu, Madeleine K D Scott, Cesar Marquez, et al.
Journal of Cutaneous Pathology|October 9, 2020
ALK-positive compound Spitz nevus with extensive perineural and intraneural neurotropismRyanne A Brown, Jennifer Y Wang, Shyam S Raghavan, et al.
Diagnostic Pathology|September 29, 2020
Cutaneous T-cell lymphomas with pathogenic somatic mutations and absence of detectable clonal T-cell receptor gene rearrangement: two case reportsRebecca Rojansky, Sebastian Fernandez-Pol, Erica Wang, et al.
Journal of the American Academy of Dermatology|December 10, 2020
Clinicopathologic characterization of enfortumab vedotin-associated cutaneous toxicity in patients with urothelial carcinomaKelsey E Hirotsu, Jasmine Rana, Jennifer Y Wang, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Pigment Cell & Melanoma Research|January 24, 2019
Biomarker discovery analysis: Alterations in p14, p16, p53, and BAP1 expression in nevi, cutaneous melanoma, and metastatic melanomaMichael R Sargen, Jeffrey M Cloutier, Kavita Y Sarin, et al.
Journal of Cutaneous Pathology|March 24, 2020
TERT and TERT promoter in melanocytic neoplasms: Current concepts in pathogenesis, diagnosis, and prognosisKiran Motaparthi, Jinah Kim, Aleodor A Andea, et al.
Journal of Cutaneous Pathology|July 19, 2020
Diffuse PRAME expression is highly specific for malignant melanoma in the distinction from clear cell sarcomaShyam S Raghavan, Jennifer Y Wang, Angus Toland, et al.
Journal of Cutaneous Pathology|January 14, 2017
Gain of CD26 expression on the malignant T-cells in relapsed erythrodermic leukemic mycosis fungoidesFiliberto Cedeno-Laurent, Maria Wysocka, Amrom E Obstfeld, et al.
Journal of Cutaneous Pathology|June 21, 2025
Metastatic Gastrointestinal Stromal Tumor to the Scalp: A Case Report Highlighting Diagnostic Challenges and Molecular CorrelationAndrew C Sanchez, Oyewale O Shiyanbola, Xiaohua Qian, et al.
Journal of Cutaneous Pathology|July 25, 2018
Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologistsPatrick O Emanuel, Aleodor A Andea, Claudia I Vidal, et al.
Journal of the American Academy of Dermatology|December 7, 2021
Histologic subtype of cutaneous immune-related adverse events predicts overall survival in patients receiving immune checkpoint inhibitorsKelsey E Hirotsu, Madeleine K D Scott, Cesar Marquez, et al.
Journal of Cutaneous Pathology|October 9, 2020
ALK-positive compound Spitz nevus with extensive perineural and intraneural neurotropismRyanne A Brown, Jennifer Y Wang, Shyam S Raghavan, et al.
Diagnostic Pathology|September 29, 2020
Cutaneous T-cell lymphomas with pathogenic somatic mutations and absence of detectable clonal T-cell receptor gene rearrangement: two case reportsRebecca Rojansky, Sebastian Fernandez-Pol, Erica Wang, et al.
Journal of the American Academy of Dermatology|December 10, 2020
Clinicopathologic characterization of enfortumab vedotin-associated cutaneous toxicity in patients with urothelial carcinomaKelsey E Hirotsu, Jasmine Rana, Jennifer Y Wang, et al.
Pageof 7